FDA-Drug2021-02-10Class II
Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1
Taro Pharmaceuticals U.S.A., Inc.
Hazard
CGMP deviations.
Sold states
Nationwide
Affected count
44,256 bottles
Manufactured in
3 Skyline Dr, Hawthorne, NY, United States
Products
Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0246-2021Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief